A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis.

导出 OA

翻译打印收藏纠错

作者： Cynthia,Aranow ^[1] ; John,Cush ^[2] ; Marcy B,Bolster ^[3] ; Christopher C,Striebich ^[4] ; Maria,Dall'era ^[5] ; Meggan,Mackay ^[1] ; Ewa,Olech ^[6] ; Tracy,Frech ^[7] ; Jane,Box ^[8] ; Richard,Keating ^[9] ; Mary Chester,Wasko ^[10] ; William,St Clair ^[11] ; Alan,Kivitz ^[12] ; Weiquang,Huang ^[1] ; PetaGay,Ricketts ^[1] ; Beverly,Welch ^[13] ; Sherrie,Callahan ^[13] ; Meagan,Spychala ^[14] ; Karen,Boyle ^[14] ; Kate,York ^[14] ; Lynette,Keyes-Elstein ^[14] ; Ellen,Goldmuntz ^[13] ; Betty,Diamond ^[1] ; Anne,Davidson ^[1]

作者单位： The Feinstein Institute for Medical Research, Manhasset, USA. ^[1] Division of Rheumatology, Baylor University Medical Center, Dallas, USA. ^[2] Division of Rheumatology, Massachusetts General Hospital, Boston, USA. ^[3] Division of Rheumatology, University of Colorado, Denver, USA. ^[4] Division of Rheumatology, University of California, San Francisco, USA. ^[5] Department of Internal Medicine, University of Nevada School of Medicine, Las Vegas, USA. ^[6] Department of Internal Medicine, University of Utah, Internal Medicine, Salt Lake City, USA. ^[7] Box Arthritis & Rheumatology of the Carolinas, Charlotte, USA. ^[8] Division of Rheumatology, Scripps Green Hospital, La Jolla, USA. ^[9] Division of Rheumatology, Western Pennsylvania Hospital, Pittsburgh, USA. ^[10] Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, USA. ^[11] Altoona Center for Clinical Research, Duncansville, USA. ^[12] National Institute of Allergy and Infectious Diseases, NIH, Bethesda, USA. ^[13] Rho Federal Systems Division, Chapel Hill, USA. ^[14]

关键词 C-reactive protein disease activity inflammation rheumatoid arthritis